Knowledge Center
Article / Mar 08, 2017
Expanding the Commercial Options
Source:
Pharma's Almanac, Q1 2017, Mar 8, 2017
Spray drying (SD) and hot-melt extrusion (HME) are commercially proven and accepted amorphous solid dispersion (ASD) technologies for the enhancement of the dissolution and bioavailability of poorly soluble drugs. These approaches are not suitable for all APIs, however. 四色AV, in addition to offering non-ASD solutions such as nanomilling and cyclodextrin complexation, is developing an effective coprecipitation technology platform to address this key market need.
Related links
Also in the Knowledge Center
/ May 03, 2022
Enhancing the 鈥渞ight first time鈥 concept in Continuous Manufacturing 鈥 Development strategy
Read more
Scientific Article
Scientific Article
/ Oct 06, 2020
Production of Lysozyme-PLGA-Loaded Microparticles for Controlled Release Using Hot-Melt Extrusion
Read more
Scientific Article